Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

ARCT holding history

Arcturus Therapeutics Holdings Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARCT overviewAll 13F holders of ARCTFull Q2 2026 holdings

Shares (Q2 2026)
423
Value
$2.84K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARCT by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026423$2.84K<0.1%00.0%UnchangedHolders
Q1 2026423$3.27K<0.1%00.0%UnchangedHolders
Q4 2025423$2.59K<0.1%00.0%UnchangedHolders
Q3 2025423$7.80K<0.1%−7,364−94.6%ReducedHolders
Q2 20257,787$101.3K<0.1%+4,394+129.5%AddedHolders
Q1 20253,393$35.9K<0.1%+2,329+218.9%AddedHolders
Q4 20241,064$18.1K<0.1%−23−2.1%ReducedHolders
Q3 20241,087$25.2K<0.1%−90−7.6%ReducedHolders
Q2 20241,177$28.7K<0.1%−34−2.8%ReducedHolders
Q1 20241,211$40.9K<0.1%00.0%UnchangedHolders
Q4 20231,211$38.2K<0.1%+25+2.1%AddedHolders
Q3 20231,186$30.3K<0.1%−47−3.8%ReducedHolders
Q2 20231,233$35.4K<0.1%−54−4.2%ReducedHolders
Q1 20231,287$30.8K<0.1%+26+2.1%AddedHolders
Q4 20221,261$21.4K<0.1%+513+68.6%AddedHolders
Q3 2022748$11.0K<0.1%−118−13.6%ReducedHolders
Q2 2022866$14.0K<0.1%−776−47.3%ReducedHolders
Q1 20221,642$44.0K<0.1%+121+8.0%AddedHolders
Q4 20211,521$57.0K<0.1%+313+25.9%AddedHolders
Q3 20211,208$58.0K<0.1%−714−37.1%ReducedHolders
Q2 20211,922$65.0K<0.1%+152+8.6%AddedHolders
Q1 20211,770$73.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.